Skip to main content
OpenTrials
Completed

NCT Number: NCT02544230

Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia

The investigators retrospectively evaluated the efficacy of granulocyte transfusions as adjunctive treatment for severe infections in neutropenic fever unresponsive to antimicrobial therapy in hematological patients.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • fever;
  • presence of absolute neutrophil count <0.5 x 10^9/L
  • evidence of bacterial or fungal infections (including clinical signs of infection, positive cultures or biopsy, and radiological evidences)
  • unresponsiveness to appropriate antimicrobial therapy for at least 48 hours

Exclusion criteria

  • none

Treatment and study plan

Primary outcomes

  1. Infection-related mortality

    Time frame: within 30 days after the last granulocyte transfusion

    deaths due to infection occurred within 30 days after the last granulocyte transfusion

Sponsors and collaborators

Lead sponsor

Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne

Other

Registry information

Official study title

Efficacy of Granulocyte Transfusions for the Treatment of Severe Infections in Hematological Patients With Febrile Neutropenia

Important dates

Study start
2004
Primary completion
2011
Study completion
2011
First posted
Sep 9, 2015
Registry last updated
Sep 9, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.